Buscar resultados de ensayos clínicos
Salivary Gland Neoplasms - 20 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer Condición: Salivary Gland Cancer Fecha: 2014-01-23 Intervenciones:
|
Recruiting |
Nombre del estudio: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer Condición: Salivary Gland Cancer Fecha: 2013-09-24 Intervenciones:
|
Recruiting |
Nombre del estudio: Activity of Sorafenib in Salivary Gland Cancer Condición: Salivary Gland Cancer Fecha: 2012-04-06 Intervenciones: Drug: Sorafenib 400 mg twice daily, on a continuous basis (each morning and evening), in 4 week cycles |
Active, not recruiting |
Nombre del estudio: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer Condición:
|
Completed |
Nombre del estudio: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Condición:
Fecha: 2004-11-05 Intervenciones: |
Active, not recruiting |
Nombre del estudio: Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck Condición: Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck Fecha: 2015-09-22 Intervenciones: Drug: BIBF1120 Nintedanib will be given orally at a dose of 200mg twice daily (bid) until progression or |
Not yet recruiting |
Nombre del estudio: Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma Condición: Salivary Gland Carcinoma Fecha: 2015-03-13 Intervenciones: Drug: pazopanib treatment will be given until progression or unacceptable toxicity . |